Cuál es el precio por Hemp, Inc (HEMP)

Precio por Hemp, Inc (HEMP) es de$0.00005

Cuál es la capitalización de mercado por Hemp, Inc (HEMP)

Capitalización de mercado por Hemp, Inc (HEMP) es $882.95K

Ingresos de Hemp, Inc (HEMP)

Hemp, Inc. operates primarily within the industrial hemp sector. Its diverse product range includes various hemp-derived offerings, such as their "King of Hemp" pre-roll blends, fortified pre-rolls, Bubba Kush hemp flower, specialized caviar/moon rocks, and concentrated diamonds and crumbles. Beyond retail products, the company is actively involved in the cultivation and processing of industrial hemp, alongside the extraction of CBD oil. It also plays a crucial role in empowering and educating hemp farmers and entrepreneurs, supplying them with vital knowledge, processing capabilities, infrastructure, and general support. Furthermore, Hemp, Inc. offers a wide array of hemp-related accessories and equipment for sale, encompassing extractors, harvesters, storage solutions, various containers, fertilizers, soil amendments, humidity control devices (humidifiers and dehumidifiers), balers, and comprehensive greenhouse systems. The firm extends its services to other hemp cultivators, providing post-harvest activities such as drying, trimming, curing, storing, and brokering harvested hemp. Complementing these activities, it also conducts research and development, offers professional hemp consulting, and delivers engaging educational entertainment. Established in 2008, the company initially operated as Marijuana, Inc. before officially rebranding to Hemp, Inc. in June 2012. Its corporate headquarters are located in Las Vegas, Nevada.

Año	Ingresos	Cambiar
Not enough data for the provided dates.

Año

Ingresos

Cambiar

Not enough data for the provided dates.

Empresa	Ingresos	Diferencia de ingresos	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$6.61B	-	IN

Empresa

Ingresos

Diferencia de ingresos

País